SCHEMBL20077463

SCHEMBL20077463

COC(=O)CCN(CCC(=O)OC)CCS(Cl)(Cl)Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
TSHR P16473 4/20 0.44
CA12 O43570 3/20 0.38
CA14 Q9ULX7 3/20 0.38
LMNA P02545 3/20 0.34
KDM4E B2RXH2 1/20 0.34
KDM5A P29375 2/20 0.34
HSD17B10 Q99714 2/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 1/20 0.33
KAT2B Q92831 2/20 0.33
GAA P10253 2/20 0.32
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CA7 P43166 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64783 0.83 KMT2A (0.65) KMT2AMEN1TSHRCA12CA14
SCHEMBL2055303 0.81 KMT2A (0.62) KMT2AMEN1TSHRCA12CA14
SCHEMBL2055299 0.81 KMT2A (0.62) KMT2AMEN1TSHRCA12CA14
SCHEMBL12791521 0.81 KMT2A (0.62) KMT2AMEN1TSHRCA12CA14
SCHEMBL2055295 0.81 KMT2A (0.62) KMT2AMEN1TSHRCA12CA14
SCHEMBL14575726 0.81 KMT2A (0.48) KMT2AMEN1TSHRCA12CA14
SCHEMBL19784710 0.79 TSHR (0.57) KMT2AMEN1TSHRCA12CA14
SCHEMBL10598283 0.78 KMT2A (0.54) KMT2AMEN1TSHRCA12CA14
SCHEMBL2055296 0.77 KMT2A (0.58) KMT2AMEN1TSHRCA12CA14
SCHEMBL2055302 0.77 KMT2A (0.58) KMT2AMEN1TSHRCA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10707524-B2 Graphene compound and manufacturing method thereof, electrolyte, and power storage device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-07-07 US disclosed
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10707524-B2 Graphene compound and manufacturing method thereof, electrolyte, and power storage device ILK, GK, KCNH3 KMT2A 1311/4885MEN1 4232/4885TSHR 3831/4885
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE ILK, GK, KCNH3 KMT2A 1311/4885MEN1 4232/4885TSHR 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.